Final Continuous Glucose Monitor (CGM) Policy Released

Published in Home Medical Equipment on March 07, 2023

Final Continuous Glucose Monitor (CGM) Policy ReleasedThis article was originally written by The van Halem Group

Medicare released the final draft of the new Glucose Monitor LCD and Policy Article with an effective date of April 16, 2023. The change was completed after a response to comments for the LCD. This new policy revamps the current CGM coverage criteria with some highlights below.

Initial Coverage

The beneficiary for whom a CGM is being prescribed can be insulin treated or non-insulin treated with additional criteria.

  • The beneficiary is insulin-treated; or,
  • The beneficiary has a history of problematic hypoglycemia with documentation of at least one of the following:
    • Beneficiaries with non-insulin treated diabetes and a history of recurrent (more than one) level 2 hypoglycemic events.
  • The treating practitioner must document at least one of the following in the medical record for each event: 
    • The glucose values for the qualifying event(s) (glucose <54mg/dL (3.0mmol/L)); or,
    • Classification of the hypoglycemic episode(s) as level 2 event(s); or,
    • Incorporate a copy of the beneficiary’s BGM testing log into the medical record reflecting the specific qualifying events (glucose <54mg/dL (3.0mmol/L)); and,
    • Documentation of more than one previous medication adjustment and/or modification to the treatment plan (such as raising A1c targets) prior to the most recent level two event.
  • Beneficiaries with non-insulin treated diabetes and a history of at least one level 3 hypoglycemic event
  • The treating practitioner must document at least one of the following in the medical record:
    • The glucose value for the qualifying event (glucose <54mg/dL (3.0mmol/L)); or,
    • Classification of the hypoglycemic episode as level 3 event; or,
    • Incorporate a copy of the beneficiary’s BGM testing log into the medical record reflecting the specific qualifying event (glucose <54mg/dL (3.0mmol/L)); and,
    • An indication in the medical record that the beneficiary required third party assistance for treatment.

They also added the language that patient evaluations with the treating practitioner can be in-person or Medicare-approved telehealth visit with the beneficiary.

Continued Coverage

Coverage criteria for continued coverage notes “the treating practitioner conducts an in-person or Medicare-approved telehealth visit with the beneficiary to document adherence to their CGM regimen and diabetes treatment plan every six (6) months following the initial prescription for CGM. Medicare indicated that there is no requirement for the treating practitioner to reconfirm the initial coverage are met for continued coverage.

Modifiers

For blood glucose monitors (codes E0607, E2100, E2101) and related supplies (codes A4233, A4234, A4235, A4236, A4244, A4245, A4246, A4247, A4250, A4253, A4255, A4256, A4257, A4258, A4259) and CGM devices (code E2102 or E2103) and supply allowance (code A4238 or A4239), the following modifiers must be added to the code(s) on every claim submitted:

  • Use modifier KX if the beneficiary is insulin treated; or,
  • Use modifier KS if the beneficiary is non-insulin treated.

Contact The van Halem Group at info@vanhalemgroup.com for any questions.


TAGS

  1. medicare
  2. vgm
  3. wound care

From Our Experts

Celebrating the Heroes of Respiratory Care: A Personal Perspective thumbnail Celebrating the Heroes of Respiratory Care: A Personal Perspective VGM's Emily Southall, Sleep Services Manager, shares what Respiratory Care Week, celebrated from October 20-26, 2024, means to her as a respiratory therapist. [Vlog] Reconsideration Request for RAD and HVM Policy thumbnail [Vlog] Reconsideration Request for RAD and HVM Policy Listen in as Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares that CMS has released a reconsideration request for the RAD and HVM policy. Value-Based Approaches to Wound Care Management thumbnail Value-Based Approaches to Wound Care Management In the context of wound care, value-based care emphasizes the importance of outcomes-driven, evidence-based treatment plans that reward the quality and efficiency of services. The Future of PAP Adherence with the Use of AI thumbnail The Future of PAP Adherence with the Use of AI AI holds the key to transforming our current approach to sleep medicine in diagnostics, therapeutics, and workflow practice management. Leveraging Data and Compliance for Referral Source Growth and Increased Cash Flow thumbnail Leveraging Data and Compliance for Referral Source Growth and Increased Cash Flow In today's post-acute healthcare landscape, providers often wonder how to enhance referral source growth and boost cash flow. Advancements in Respiratory Technology: Shaping the Future of Patient Care thumbnail Advancements in Respiratory Technology: Shaping the Future of Patient Care The field of respiratory care is rapidly evolving, driven by technological innovations that promise better patient outcomes and enhanced quality of life. Breaking Into the Wound Care Space: How to be Successful in the Dressings Market thumbnail Breaking Into the Wound Care Space: How to be Successful in the Dressings Market To be successful in the wound care market, consider this five-step approach to breaking into the wound care space. Why Rent When I Can Own? thumbnail Why Rent When I Can Own? Why would a provider want to rent their ventilator fleet rather than own their own assets? It all boils down to risk and investments. To own a ventilator rental fleet can be incredibly expensive. Beyond the acquisition cost, warehousing space, inventory tracking, preventative maintenance, property insurance, and risk mitigation should be considered when factoring in the purchase price of equipment. How many ventilators are currently in your warehouse?